Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement

NCT00507962 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Cisplatin
DRUG: Liposomal Doxorubicin

Sponsor

M.D. Anderson Cancer Center